Current Report Filing (8-k)
04 April 2023 - 8:05PM
Edgar (US Regulatory)
0001533030
false
0001533030
2023-04-03
2023-04-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) April 3, 2023
Cryomass Technologies Inc
(Exact name of registrant as specified in its charter)
| Nevada |
|
000-56155 |
|
82-5051728 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
| 1001 Bannock St Suite 612, DenverCO |
|
80204 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code 303-416-7208
(Andina
Gold Corp.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of Each Class |
|
Trading
Symbol |
|
Name
of each Exchange on which Registered |
| None |
|
|
|
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
4.01. Change in Registrant's Certifying Accountant
On
April 3, 2023, the Audit Committee (the “Audit Committee”) of the Board of Directors of Cryomass Technologies Inc, a Nevada
corporation (the “Company”), approved the engagement of Macias Gini & O’Connel LLP (“MGO”) as the Company’s
independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023, effective immediately, and
resolved to terminate BF Borgers CPA PC (“Borgers”) as the Company's independent registered public accounting firm, effective
immediately. Borger’s audit reports on the Company’s consolidated financial statements as of and for the fiscal years ended
December 31, 2021 and 2022 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty,
audit scope or accounting principles. During the fiscal years ended December 31, 2021, and 2022, and the subsequent interim periods through
March 23, 2023, there were (i) no disagreements (as described in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between
the Company and Borgers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure,
which, if not resolved to Borgers’s satisfaction, would have caused Borgers to make reference thereto in their reports on the financial
statements for such years, and (ii) no “reportable events” within the meaning of Item 304(a)(1)(v) of Regulation. The Company
provided Borgers with a copy of the disclosures it is making in this Current Report on Form 8-K and requested that Borgers furnish a
letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made herein. A copy of
Borger’s letter dated April 3, 2023, is filed as Exhibit 16.1 hereto. During the fiscal years ended December 31, 2021, and 2022,
and the subsequent interim periods through the date of MGO’s engagement, neither the Company nor anyone acting on its behalf has
consulted with MGO regarding (i) the application of accounting principles to a specific transaction, either completed or proposed, or
the type of audit opinion that might be rendered on the Company’s financial statements or the effectiveness of internal control
over financial reporting, and neither a written report or oral advice was provided to the Company that MGO concluded was an important
factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, (ii) any matter
that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K, or (iii) any reportable event within
the meaning of Item 304(a)(1)(v) of Regulation S-K.
The
Company has provided Borgers a copy of the disclosures in this report and has requested that Borgers furnish it with a letter addressed
to the Securities and Exchange Commission stating whether or not Borgers agreed with the Company’s statements in this Item 4.01.
A copy of the letter, dated [April 3, 2023] furnished by Borgers in response to that request is filed as Exhibit 16.1 to this Report.
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits.
NOTE
REGARDING FORWARD LOOKING STATEMENTS
Any
statements in this Current Report on Form 8-K or any exhibit hereto about future expectations, plans, and prospects for the Company,
including statements about Company’s future expectations, beliefs, goals, plans, or prospects, constitute “forward-looking
statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. In some cases you can
identify forward-looking statements because they contain words such as “anticipate,” “believe,” “continue,”
“could,” “estimate,” “expect,” “intend,” “may,” “might,” “likely,”
“plan,” “potential,” “predict,” “project,” “seek,” “should,”
“target,” “will,” “would,” or similar expressions and the negatives of those terms.
These
forward-looking statements involve risks, uncertainties, and assumptions that could cause actual performance or results to differ materially
from those expressed or suggested by the forward-looking statements. If any of these risks or uncertainties materialize, or if any of
Company’s assumptions prove incorrect, its actual results could differ materially from the results expressed or implied by these
forward-looking statements. These risks and uncertainties include risks associated with: Company’s ability to achieve or maintain
profitability, and to effectively manage its anticipated growth; and the risks described in the other filings Company makes with the
Securities and Exchange Commission from time to time, including the risks described under the heading “Risk Factors” in Company’s
Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q, and which should be read
in conjunction with its financial results and forward-looking statements. All forward-looking statements in this Current Report on Form
8-K or any exhibit hereto are based on information available to Company as of the date hereof, and it does not assume any obligation
to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they
were made, except as required by law.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Cryomass
Technologies Inc
| /s/
Christian Noël |
|
| Christian
Noël |
|
| CEO |
|
| |
|
| Date: April
3, 2023 |
|
2
CryoMass Technologies (QB) (USOTC:CRYM)
Historical Stock Chart
From Nov 2024 to Dec 2024
CryoMass Technologies (QB) (USOTC:CRYM)
Historical Stock Chart
From Dec 2023 to Dec 2024
